Inventor · disambiguated record
Catherine Coulter
Also filed as: COULTER CATHERINE
3 granted patents·5 pending applications·3 citations·filing 2012–2019
58Inventor score
Technology areasA61P
Files withALLERGAN PHARMACEUTICALS INT LTD3WARNER CHILCOTT CO LLC3COULTER CATHERINE1PARATEK PHARM INNC1
Top patents by PatentIndex Score
8 records- 0168US10688057B25-aminosalicylic acid capsule formulationALLERGAN PHARMACEUTICALS INT LTD·Filed 2019·Granted Jun 23, 2020·1 cites·18 claims
- 0267US9255068B2Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the sameCOULTER CATHERINE·Filed 2012·Granted Feb 9, 2016·2 cites·72 claims
- 0358US2020024223A1Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the sameALLERGAN PHARMACEUTICALS INT LTD·Filed 2019·Application pending·0 cites
- 0455US2019040002A1Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the sameALLERGAN PHARMACEUTICALS INT LTD·Filed 2018·Application pending·0 cites
- 0554US10265273B25-aminosalicyclic acid capsule formulationWARNER CHILCOTT CO LLC·Filed 2014·Granted Apr 23, 2019·0 cites·24 claims
- 0648US2016200671A1Crystalline salts of (4s, 4as, 5ar, 12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the sameWARNER CHILCOTT CO LLC·Filed 2015·Application pending·0 cites
- 0746US2014141075A15-aminosalicylic acid capsule formulationWARNER CHILCOTT CO LLC·Filed 2012·Application pending·0 cites
- 0840US2013302442A1Methods of using (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amidePARATEK PHARM INNC·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →